Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Cvs Group Plc LSE:CVSG London Ordinary Share GB00B2863827 ORD 0.2P
  Price Change % Change Share Price Shares Traded Last Trade
  10.00 0.49% 2,062.00 89,576 16:35:13
Bid Price Offer Price High Price Low Price Open Price
2,056.00 2,060.00 2,076.00 2,030.00 2,064.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Retailers 510.10 33.10 27.30 75.5 1,467
Last Trade Time Trade Type Trade Size Trade Price Currency
18:45:01 O 822 2,050.56 GBX

Cvs (CVSG) Latest News (1)

More Cvs News
Cvs Investors    Cvs Takeover Rumours
Smart Money!
CVSG is a large holding in the following funds:
 Fund  Percentage of Fund  Last Updated 
 BLACKROCK THROGMORTON TRUST PLC 2.60% 2022-03-31
 BLACKROCK SMALLER COMPANIES TRUST PLC 2.80% 2022-12-31

Cvs (CVSG) Discussions and Chat

Cvs Forums and Chat

Date Time Title Posts
30/1/202306:32CVS Group: VETS,All things bright and beautiful734
07/10/201919:38Concerns founded?33

Add a New Thread

Cvs (CVSG) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Cvs trades in real-time

Cvs (CVSG) Top Chat Posts

Top Posts
Posted at 04/2/2023 08:20 by Cvs Daily Update
Cvs Group Plc is listed in the General Retailers sector of the London Stock Exchange with ticker CVSG. The last closing price for Cvs was 2,052p.
Cvs Group Plc has a 4 week average price of 1,870p and a 12 week average price of 1,870p.
The 1 year high share price is 2,134p while the 1 year low share price is currently 1,512p.
There are currently 71,146,238 shares in issue and the average daily traded volume is 182,462 shares. The market capitalisation of Cvs Group Plc is £1,467,035,427.56.
Posted at 30/1/2023 06:32 by lomax99
Acquisitive CVS on a roll, says BerenbergVeterinary group CVS (CVSG) has increased its pace of acquisition and combined with its half-year trading update, Berenberg says shareholders should benefit from material returns.Analyst Calum Battersby reiterated his 'buy' recommendation and target price of £23.70 on the stock, which ended last week broadly unchanged at £19.28.A first half 2023 update from the group was in line with Battersby's estimates and at the upper end of management's guided growth range, with like-for-like sales up 7.5% over the period and earnings rising 19%.'More interesting was a further acquisition update, stating that CVS completed the acquisition of nine veterinary practices in the UK in the first half, for a total initial consideration of £26.5m,' he said.'Given that the group has only spent an average of £16m a year over the last three years, this shows that the pace of M&A is increasing, in line with the group's stated ambition to spend upwards of £50m a year on acquisitions over the next five years.'Battersby said the acquisitions combined with the trading update 'supports our investment case, that a combination of organic growth, significant capital investments on practice refurbishments and relocations, and M&A, will all combine to drive a double-digit earnings compound annual growth rate over the next five years, supporting material shareholder returns'.
Posted at 26/1/2023 07:54 by lomax99
Decent update from CVSG. Keen to see them get back on the acquisition trail/build up greenfield sites, assuming delivery at a reasonable cost.
Posted at 23/11/2022 08:10 by waldron
Dividend

As previously announced, and subject to shareholder approval at the AGM, CVS intends to pay a dividend of 7.0 pence per ordinary share on 2 December 2022 to holders on the register as at 18 November 2022. The ex-dividend date for this timetable is 17 November 2022.

Outlook

We continue to focus on our purpose to provide the best possible care to animals through our integrated platform and to invest in our practices and clinical equipment to drive organic growth, whilst continuing to explore acquisition opportunities in both the UK and internationally. Whilst mindful of the wider macro-economic uncertainty, the Group continues to trade in line with full year market expectations and the Group remains well placed to achieve further growth over the longer term and deliver on our ambitions as set out at the CMD.

The Board recognises the opportunity to further increase its diversity, and commenced a formal search process to appoint an additional Non-Executive Director in the previous financial year. The Board is determined to select the most appropriate candidate, and is confident that this search process will be concluded with a suitable appointment in the current financial year.

The Board would like to thank all members of the CVS team for their continued dedication and support.

Posted at 22/9/2022 08:33 by maywillow
Previous dividend

Final
Per share 6.5p

Next dividend 7p

Ex-div date 23 Nov 2022


Pay date 2 Dec 2022

EDITED TO CHANGE DATES
THANKS ARIANE

Posted at 22/9/2022 08:22 by maywillow
Consensus



Mean consensus BUY

Number of Analysts 8

Last Close Price 1 610,00 GBX

Average target price 2 329,29 GBX
Spread / Average Target 44,7%

High Price Target 2 750,00 GBX
Spread / Highest target 70,8%

Low Price Target 2 075,00 GBX
Spread / Lowest Target 28,9%

Posted at 01/9/2022 15:10 by prokartace
Nothing I guess. If you look back over the past year you will seethat this type of movement downwards has happened on 4 separate occasions so I guess its just the nature of this particular share.
Posted at 25/3/2022 13:22 by tomps2
CVS Group (CVSG) interim results 2022 - March 2022

CEO, Richard Fairman, CFO, Robin Alfonso and COO, Ben Jacklin present the interim results for the period ended 31 December 2021.

Watch the video here: www.piworld.co.uk/company-videos/cvs-group-cvsg-interim-results-2022-march-2022/

Or listen to the podcast here: piworld.podbean.com/e/cvs-group-cvsg-interim-results-2022-march-2022/

Posted at 24/3/2022 09:19 by tomps2
CVS Group (CVSG) 2022 interim results overview March 2022

CEO, Richard Fairman summarises the interim results for the period ended 31 December 2021.

Watch the video here: Https://www.piworld.co.uk/company-videos/cvs-group-cvsg-2022-interim-results-overview-march-2022/

Or listen to the podcast here: Https://piworld.podbean.com/e/cvs-group-cvsg-2022-interim-results-overview-march-2022/

Posted at 18/2/2022 12:47 by robertball
Anyway, the share price reaction tells youAll you need to know. Avoid
Posted at 15/2/2022 18:25 by km18
...from last year....


Company overview:CVSG is one of the largest integrated veterinary services providers in UK with more than 480 surgeries in UK, Netherlands, and Ireland, four laboratories and seven pet crematoria. The company operates Animal Direct, which is an online store selling animal related products such as food, medicines etc. The company is focused on delivering quality clinical care based on industry-leading clinical training and implementation of innovative techniques across practices. The group has been following a hybrid path of both acquisitions and organic growth from development of their investments and personnel. CVSG has seen strong growth in both sales and EBITDA during the interim reports in December and the latest trading update on 20/07/2021. EBITDA is expected to be above H1 FY21 of 18.4% driven by strong trading momentum....from WealthOracleAM

https://wealthoracle.co.uk/detailed-result-full/CVSG/7

Cvs share price data is direct from the London Stock Exchange
Your Recent History
LSE
CVSG
Cvs
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230205 04:56:33